Age of onset is highly significant in various neurodegenerative diseases, as it correlates with the disease’s clinical phenotype and progression.
← all excerpts
Effects of STN-DBS on cognition and mood in young-onset Parkinson's disease: a two-year follow-up.
1
—
—